| Cash Flow | 2025-09-27 | 2025-06-28 |
|---|---|---|
| Net income | 31,143 | 15,487 |
| Depreciation and amortization | 28,161 | 17,051 |
| Reduction in the carrying amount of right-of-use assets | 5,228 | 3,593 |
| Stock-based compensation expense | 28,703 | 19,187 |
| Deferred income tax benefit | 3,851 | -2,639 |
| Provision for excess and obsolete inventories | 9,922 | 6,695 |
| Amortization | - | 1,339 |
| Restructuring charges | 2,119 | 2,160 |
| Gain on sale of business and assets | 103 | 103 |
| Loss (income) from equity investment | -2,316 | -3,484 |
| Other adjustments to reconcile net income to net cash provided by operating activities | -771 | -1,456 |
| Accounts receivable | 28,072 | 9,570 |
| Inventories | 13,912 | 12,367 |
| Prepaid expenses and other current assets | 4,527 | 5,717 |
| Other assets | 69 | -460 |
| Accounts payable | 5,699 | 9,649 |
| Accrued liabilities | -996 | -4,409 |
| Other liabilities | 596 | 2,487 |
| Deferred revenues | 6,188 | 1,133 |
| Operating lease liabilities | -6,053 | -4,032 |
| Net cash provided by operating activities | 69,423 | 42,432 |
| Acquisition of property, plant and equipment | 92,345 | 84,840 |
| Proceeds from sale of business and assets | 103 | 103 |
| Purchase of equity investment | 67,156 | 67,156 |
| Purchases of marketable securities | 95,378 | 73,823 |
| Purchase of promissory note receivable | 0 | - |
| Proceeds from maturities and sales of marketable securities | 98,281 | 62,503 |
| Net cash used in investing activities | -156,495 | -163,213 |
| Proceeds from issuances of common stock | 26,119 | 21,576 |
| Purchase of common stock through stock repurchase program, including excise tax paid | 26,244 | 24,586 |
| Tax withholdings related to net share settlements of equity awards | 8,609 | 3,619 |
| Payments on term loan | 826 | 549 |
| Net cash used in financing activities | -9,560 | -7,178 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 537 | 1,658 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | -96,095 | -126,301 |
| Cash and cash equivalents at beginning of period | 197,206 | - |
| Cash and cash equivalents at end of period | 101,111 | - |
FORMFACTOR INC (FORM)
FORMFACTOR INC (FORM)